Stock search

Ticker or company name

Abbott Laboratories

ABT · NYSE · Health Care

$107,45Down −1,07 (−0,99%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$188 bn
Div. yield
2,0%
Year to date
−13,4%
52 weeks: $81,97$132,03

Ratio score

33/100
Ratio would not consider buying

based on 9 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

2 ✓ · 2 — · 5 ✕ · 1 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM40,029,725,1
Forward P/E18,1—16,2
PEG4,7—2,2
P/S3,94,72,2
EV/EBITDA23,922,817,3
P/FCF27,8—19,5
P/B3,74,73,4

Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 33 analysts

Buy
26
Hold
7
Sell
0

Beat the EPS forecast in 1 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 20261,431,42Down −0,7%
Q2 20261,291,31Up +1,4%
Q1 20261,161,15Down −0,5%
Q4 20251,511,50Down −0,7%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue13,0 bn12,6 bn11,2 bn11,5 bn11,4 bn11,1 bn10,4 bn11,0 bn10,6 bn10,4 bn9,96 bn10,2 bn
EPS0,530,530,611,020,941,010,765,260,940,740,700,91
Margin7,1%7,4%9,6%15,5%14,5%16,0%12,8%84,1%15,5%12,5%12,3%15,6%
FCF1,22 bn1,99 bn916 m2,63 bn2,29 bn1,55 bn933 m2,15 bn2,15 bn1,43 bn627 m2,28 bn

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: purchases $4,40 m (4 people), sales $47,9 m.

NameAmountSharesPrice
moreland mary k5 Nov 2026 · sale$406 0003 500$116,00
mccoy john a. jr.2 Sep 2026 · sale$2 95827$109,54
ford robert b25 Aug 2026 · sale$20,9 m180 297$116,19
ford robert b25 Aug 2026 · sale$25,3 m218 535$115,57
morrone louis h.11 Aug 2026 · sale$642 5065 850$109,83
stratton john g7 May 2026 · open-market purchase$173 6402 000$86,82
starks daniel j27 Apr 2026 · open-market purchase$926 53710 000$92,65
boudreau philip p23 Apr 2026 · open-market purchase$201 3002 200$91,50
cushman elizabeth c.2 Mar 2026 · sale$30 398263$115,58
shroff eric2 Mar 2026 · sale$81 946709$115,58
morrone louis h.2 Mar 2026 · sale$132 2241 144$115,58
moreland mary k2 Mar 2026 · sale$70 851613$115,58
mccoy john a. jr.2 Mar 2026 · sale$67 614585$115,58
salvadori daniel gesua sive2 Mar 2026 · sale$102 288885$115,58
starks daniel j4 Feb 2026 · open-market purchase$545 2395 033$108,33

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Health Care
Exchange
NYSE
Country
US
IPO date
1 Mar 1937

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
ISRGIntuitive Surgical$437,7583would consider52,0+20,5%25,5%
MDTMedtronic$102,8878would consider25,1+9,8%13,9%
MCKMcKesson$1 105,0472would consider27,3+8,2%1,1%
SYKStryker Corporation$310,7272would consider33,0+7,9%13,8%
CVSCVS Health$88,5983would consider10,4+6,7%2,6%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.